StageAcquired | Acquired
Neuronex is a development stage pharmaceutical company focused on drugs that treat Central Nervous System (CNS) diseases and disorders. The company aims to combine clinical expertise with a thorough knowledge of the drug development process in an entrepreneurial environment, to achieve rapid success in obtaining approvals for our products. In December 2012, Neuronex was acquired by Acorda Therapeutics. The valuation of Neuronex was $6.8 million.
Missing: Neuronex's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Neuronex's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Latest Neuronex News
Aug 18, 2020
Reviewed by Emily Henderson, B.Sc.Aug 18 2020 Portland State University will join eight institutions as part of a new National Science Foundation-backed research team tasked with investigating how brains interact with their surrounding environment. The team, known as NeuroNex: Communication, Coordination, and Control in Neuromechanical Systems (C3NS), received at total of $8 million in funding from the NSF over the next five years to conduct this research -- $901,000 of which was awarded to PSU. C3NS is one of four international interdisciplinary teams receiving $50 million in NSF funding. NeuroNex was created with the objective to establish international research partnerships and accelerate the next generation of neuroscience. The teams, which include 70 researchers from the U.S. the United Kingdom and Germany, will develop new theories and tools to better understand the brain. At Portland State, we will be testing theories of mammalian neural system organization on simulated animals and on our robot, Muscle Mutt, with close collaborators at Case Western Reserve University, Northwestern University, Emory University, and the University of Jena (Germany)." Alexander Hunt, NeuroNex co-principal investigator and head of PSU's Agile and Adaptive Robotics lab PSU will also work collaboratively to develop a modeling framework synthesizing their knowledge with other researchers studying fruit flies and sea slugs as part of NeuroNex. "This project seeks to understand how nervous systems of all animals provide effective control in the dynamic and uncertain environments in which we live," Hunt said. The impacts of this research will have broad impacts on both health and robotics, Hunt said. "By better understanding how the nervous system works, we will be able to better investigate motor disorders that disrupt locomotion and balance, such as Parkinson's," Hunt added. "For robotics, we will be able to apply what we learn to develop control systems with more adaptive behavior." Source:
Neuronex Frequently Asked Questions (FAQ)
Where is Neuronex's headquarters?
Neuronex's headquarters is located at 9001 Aerial Center Parkway, Morrisville.
What is Neuronex's latest funding round?
Neuronex's latest funding round is Acquired.
How much did Neuronex raise?
Neuronex raised a total of $1.9M.
Who are the investors of Neuronex?
Investors of Neuronex include Acorda Therapeutics.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.